BetaEntity Annotation Prototype

Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed

All extracted treatments

Showing 2,821–2,880 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

alternative treatment options1ambulatory oxygen therapy1amyloid-clearing therapies1anaesthetics1analgesic strategies1androgen receptor inhibitors1aneurysm embolization1angioplasty and stenting1angiotensin II receptor blocker1anteroseptal line ablation1anthracycline-based therapy1anti- H.pylori treatment1anti-CD19 CAR-T therapy1anti-CD20 therapies1anti-CGRP therapies1anti-CTLA4 therapy1anti-HER2 therapies1anti-HER2 therapy1anti-IL5R therapy1anti-PD therapy1anti-PD-(L)1 therapy1anti-PD-1 therapies1anti-PD-1/PD-L1 therapies1anti-TB therapy1anti-TNF treatment1anti-TNF-α therapy1anti-TNFα treatment1anti-aTNF therapy1anti-amyloid immunotherapy1anti-amyloid monoclonal antibody therapies1anti-cancer interventions1anti-cancer treatments1anti-eosinophilic biologic therapy1anti-fibrinolytic treatment1anti-fungal induction therapy1anti-hypertensives1anti-infective therapy1anti-infective treatment1anti-inflammation1anti-inflammatory analgesia1anti-inflammatory diet1anti-inflammatory strategies1anti-inflammatory-based management1anti-interleukin-1 therapy1anti-metabolite therapy1anti-metastatic therapies1anti-osteoporotic medication1anti-programmed cell death ligand-1(PD-L1) therapy1anti-programmed cell death protein 1 (PD-1) therapy1anti-programmed cell death protein 1 ICB1anti-programmed cell death protein 1 immunotherapy1anti-programmed cell death protein-1 (PD-1) therapy1anti-programmed cell death-ligand 1 immunotherapy1anti-programmed death-ligand 1 therapy1anti-pyretics1anti-reflux therapy1anti-rejection medication1anti-rejection medications1anti-respiratory syncytial virus (RSV) antibody prophylaxis1anti-rheumatic therapy1

Articles mentioning treatments

7,227 articles · page 47 of 603
Parenteral nutritionmeropenemBiliary atresiabiliary atresia-relatedcholestatic liver failurepaediatric end-stage liver diseaseend-stage liver disease

…ed by intolerance, gastrointestinal bleeding or marked ascites. Parenteral nutrition, therefore, becomes an essential bridge to stabilise nutritiona…

chemotherapycetuximabDabrafenibmCRCencorafenibmetastatic colorectal cancerBRAF V600E-Mutant metastatic colorectal cancer

…usions Our findings indicate that Dabrafenib and cetuximab with chemotherapy are effective and tolerable first-line and second-line regimens…

EBACHATamoxicillinclarithromycinHelicobacter pyloritegoprazanesomeprazoleH. pylori

…BAC in the intention-to-treat analysis. HAT was non-inferior to EBAC (risk difference -1.9%, 95% CI -9.3 to 5.5), while LAT was not …

ChemoradiotherapyNon-small cell lung cancerNSCLC[18F] FDGAmerican College of Radiology Imaging Network[18F]Fluorodeoxyglucose[18F]FDG[18F] fluorodeoxyglucoseCancer Imaging Archive

…anges in [18F] FDG uptake in other organs (figure 2).Conclusion Chemoradiotherapy has adverse effects on the vasculature, possibly through increa…